Global Dna Sequencing Market 2026-2030

Description

The global dna sequencing market is forecasted to grow by USD 16421 mn during 2025-2030, accelerating at a CAGR of 15.2% during the forecast period. The report on the global dna sequencing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in precision medicine and targeted oncology, technological innovations associated dna sequencing, increasing applications in infectious disease surveillance and public health.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year	2025
End Year	2030
Series Year	2026-2030
Growth Momentum	Accelerate
YOY 2026	13.9%
CAGR	15.2%
Incremental Value	$16421 mn

Technavio's global dna sequencing market is segmented as below:

By End-User

Hospitals and clinics
Pharmaceutical and biotechnology companies
Academic research
Clinical research

By Solution

Product
Services

By Technology

Next generation sequencing
Sanger sequencing
Third generation sequencing
Others

By Application

Research
Genomics
Diagnostics
Medicine

Geography

North America
- US
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- The Netherlands
Asia
Rest of World (ROW)
Rest of World (ROW)

This study identifies the integration of ai and ml for drug discovery as one of the prime reasons driving the global dna sequencing market growth during the next few years. Also, advancements in spatial biology and single-cell transcriptomics and expansion of long-read sequencing in clinical and regulatory settings will lead to sizable demand in the market.

The report on the global dna sequencing market covers the following areas:

Global dna sequencing market sizing
Global dna sequencing market forecast
Global dna sequencing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global dna sequencing market vendors that include 10X Genomics Inc., Agilent Technologies Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Complete Genomics Inc., Dante Labs Inc., Element Biosciences Inc., Eurofins Genomics LLC, F. Hoffmann La Roche Ltd., GeneDx LLC, GENEWIZ Inc., Helix OpCo LLC, Illumina Inc., Macrogen Inc., Oxford Nanopore Technologies, Pacific Biosciences Inc., QIAGEN N.V., Tempus AI Inc., Thermo Fisher Scientific Inc., Ultima Genomics Inc.. Also, the global dna sequencing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR40874

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Solution
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
2.3 Factors of disruption
2.4 Impact of drivers and challenges

3 Market Landscape

3.1 Market ecosystem
3.2 Market characteristics
3.3 Value chain analysis

4 Market Sizing

4.1 Market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

5.1 Global DNA Sequencing Market 2020 - 2024
- Historic Market Size - Data Table on Global DNA Sequencing Market 2020 - 2024 ($ million)
5.2 End-user segment analysis 2020 - 2024
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.3 Solution segment analysis 2020 - 2024
- Historic Market Size - Solution Segment 2020 - 2024 ($ million)
5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
5.5 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.6 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.7 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on Global DNA Sequencing Market
6.2 Impact of Geopolitical Conflict on Global DNA Sequencing Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition

8 Market Segmentation by End-user

8.1 Market segments
8.2 Comparison by End-user
8.3 Hospitals and clinics - Market size and forecast 2025-2030
8.4 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
8.5 Academic research - Market size and forecast 2025-2030
8.6 Clinical research - Market size and forecast 2025-2030
8.7 Market opportunity by End-user
- Market opportunity by End-user ($ million)

9 Market Segmentation by Solution

9.1 Market segments
9.2 Comparison by Solution
9.3 Product - Market size and forecast 2025-2030
9.4 Services - Market size and forecast 2025-2030
9.5 Market opportunity by Solution
- Market opportunity by Solution ($ million)

10 Market Segmentation by Technology

10.1 Market segments
10.2 Comparison by Technology
10.3 Next generation sequencing - Market size and forecast 2025-2030
10.4 Sanger sequencing - Market size and forecast 2025-2030
10.5 Third generation sequencing - Market size and forecast 2025-2030
10.6 Others - Market size and forecast 2025-2030
10.7 Market opportunity by Technology
- Market opportunity by Technology ($ million)

11 Market Segmentation by Application

11.1 Market segments
11.2 Comparison by Application
11.3 Research - Market size and forecast 2025-2030
11.4 Genomics - Market size and forecast 2025-2030
11.5 Diagnostics - Market size and forecast 2025-2030
11.6 Medicine - Market size and forecast 2025-2030
11.7 Market opportunity by Application
- Market opportunity by Application ($ million)

12 Customer Landscape

12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

13.1 Geographic segmentation
13.2 Geographic comparison
13.3 North America - Market size and forecast 2025-2030
- 13.3.1 US - Market size and forecast 2025-2030
- 13.3.2 Canada - Market size and forecast 2025-2030
- 13.3.3 Mexico - Market size and forecast 2025-2030
13.4 Europe - Market size and forecast 2025-2030
- 13.4.1 UK - Market size and forecast 2025-2030
- 13.4.2 Germany - Market size and forecast 2025-2030
- 13.4.3 France - Market size and forecast 2025-2030
- 13.4.4 Italy - Market size and forecast 2025-2030
- 13.4.5 Spain - Market size and forecast 2025-2030
- 13.4.6 The Netherlands - Market size and forecast 2025-2030
13.5 Asia - Market size and forecast 2025-2030
- 13.5.1 Japan - Market size and forecast 2025-2030
- 13.5.2 China - Market size and forecast 2025-2030
- 13.5.3 India - Market size and forecast 2025-2030
- 13.5.4 South Korea - Market size and forecast 2025-2030
- 13.5.5 Thailand - Market size and forecast 2025-2030
- 13.5.6 Singapore - Market size and forecast 2025-2030
13.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 13.6.1 Brazil - Market size and forecast 2025-2030
- 13.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 13.6.3 UAE - Market size and forecast 2025-2030
- 13.6.4 Turkey - Market size and forecast 2025-2030
- 13.6.5 Argentina - Market size and forecast 2025-2030
- 13.6.6 Colombia - Market size and forecast 2025-2030
- 13.6.7 South Africa - Market size and forecast 2025-2030
- 13.6.8 Israel - Market size and forecast 2025-2030
13.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity

14.1 Market drivers
- Advancements in precision medicine and targeted oncology
- Technological innovations associated DNA sequencing
- Increasing applications in infectious disease surveillance and public health
14.2 Market challenges
- High initial investment and operational costs
- Limited standardization and interoperability of technologies and data
- Data management and analytical complexity in genomics
14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
14.4 Market opportunities
- Integration of AI and ML for drug discovery
- Advancements in spatial biology and single-cell transcriptomics
- Expansion of long-read sequencing in clinical and regulatory settings

15 Competitive Landscape

15.1 Overview
15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
- Overview on factors of disruption
15.4 Industry risks
- Impact of key risks on business

16 Competitive Analysis

16.1 Companies profiled
- Companies covered
16.2 Company ranking index
- Company ranking index
16.3 Market positioning of companies
- Matrix on companies position and classification
16.4 10X Genomics Inc.
- 10X Genomics Inc. - Overview
- 10X Genomics Inc. - Product / Service
- 10X Genomics Inc. - Key offerings
- SWOT
16.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
16.6 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
16.7 Dante Labs Inc.
- Dante Labs Inc. - Overview
- Dante Labs Inc. - Product / Service
- Dante Labs Inc. - Key offerings
- SWOT
16.8 Element Biosciences Inc.
- Element Biosciences Inc. - Overview
- Element Biosciences Inc. - Product / Service
- Element Biosciences Inc. - Key offerings
- SWOT
16.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
16.10 GeneDx LLC
- GeneDx LLC - Overview
- GeneDx LLC - Product / Service
- GeneDx LLC - Key offerings
- SWOT
16.11 GENEWIZ Inc.
- GENEWIZ Inc. - Overview
- GENEWIZ Inc. - Product / Service
- GENEWIZ Inc. - Key offerings
- SWOT
16.12 Helix OpCo LLC
- Helix OpCo LLC - Overview
- Helix OpCo LLC - Product / Service
- Helix OpCo LLC - Key offerings
- SWOT
16.13 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
16.14 Oxford Nanopore Technologies
- Oxford Nanopore Technologies - Overview
- Oxford Nanopore Technologies - Product / Service
- Oxford Nanopore Technologies - Key offerings
- SWOT
16.15 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
16.16 Tempus AI Inc.
- Tempus AI Inc. - Overview
- Tempus AI Inc. - Product / Service
- Tempus AI Inc. - Key offerings
- SWOT
16.17 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16.18 Ultima Genomics Inc.
- Ultima Genomics Inc. - Overview
- Ultima Genomics Inc. - Product / Service
- Ultima Genomics Inc. - Key offerings
- SWOT

17 Appendix

17.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
17.3 Currency conversion rates for US$
- Currency conversion rates for US$
17.4 Research methodology
- Research methodology
17.5 Data procurement
- Information sources
17.6 Data validation
- Data validation
17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
17.8 Data synthesis
- Data synthesis
17.9 360 degree market analysis
- 360 degree market analysis
17.10 List of abbreviations
- List of abbreviations